Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
157.60    3.80 (2.47%)
Bid:
157.60
Ask:
158.00
Spread: 0.40 (0.254%)
Market Cap: £385.03m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Director/PDMR Shareholding

8 Apr 2025 15:54

RNS Number : 1810E
Sabre Insurance Group PLC
08 April 2025
 

8 April 2025

 

Sabre Insurance Group plc ("Sabre" or the "Company")

Notification of transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

Awards under the Company's Long Term Incentive Plan

The Company announces that on 8 April 2025 the following directors and PDMRs of the Company were, subject to the rules of the Sabre 2017 Long Term Incentive Plan, each granted a conditional award (the 'LTIP Award') of ordinary shares of £0.001 in the Company as detailed below:

 

Name

Position

Number of shares subject to award

Geoff Carter

Chief Executive Officer

306,131

Anneka Kingan

Chief Risk and Officer and Company Secretary

118,020

Trevor Webb

Claims Director

190,614

Adam Westwood

Chief Financial Officer

149,561

Matt Wright

Chief Actuary

149,561

 

The awards will vest on the third anniversary of their grant, and are subject to an additional retention period of two years, commencing on the awards' vesting date.

 

The vesting of the awards will be subject to the following underpins:

· that the solvency coverage ratio of the Group (being the ratio of the Group's Solvency II net assets to its Solvency Capital Requirement, calculated before the final dividend is paid, expressed as a percentage) is maintained in excess of 140% over the LTIP Period;

· that the Group has achieved a Return On Tangible Equity (being the ratio of the Group's adjusted profit after tax to its average tangible equity, expressed as a percentage) in excess of 10% for each full reporting period which falls within the LTIP Period;

· that there has been no material intervention by a regulatory authority either initiated during the LTIP Period or related to it, that results in a Group Member being required by the relevant authority to undertake actions or remedial measures; and

· overall Committee discretion.

 

This notification is made pursuant to Article 19 of the EU Market Abuse Regulation.

 

Additional Information:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.uk

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Geoff Carter

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.294

306,131

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

306,131

£1.294

 

e)

Date of transaction

8 April 2025

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Anneka Kingan

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Risk Officer and Company Secretary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.294

118,020

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

118,020

£1.294

 

e)

Date of transaction

8 April 2025

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Trevor Webb

2

 

Reason for the notification

 

a)

 

Position/status

 

Claims Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.294

190,614

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

190,614

£1.294

 

e)

Date of transaction

8 April 2025

f)

Place of transaction

London Stock Exchange (XLON)

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Adam Westwood

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.294

149,561

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

149,561

£1.294

 

e)

Date of transaction

8 April 2025

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Matt Wright

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Actuary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.294

149,561

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

149,561

£1.294

 

e)

Date of transaction

8 April 2025

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZVLFBEZLEBBL
Date   Source Headline
2nd Jun 20267:00 amRNSOn-market Share Buyback Programme of £5m
27th May 20269:36 amRNSDirector Declaration
21st May 202611:20 amRNSResult of AGM
21st May 20267:00 amRNSTrading Update
12th May 20261:22 pmRNSDirector/PDMR Shareholding
22nd Apr 20261:18 pmRNSDirector/PDMR Shareholding
14th Apr 20263:48 pmRNSDirector/PDMR Shareholding
13th Apr 20263:18 pmRNSDirector/PDMR Shareholding
8th Apr 20262:56 pmRNSDirector/PDMR Shareholding
8th Apr 202610:41 amRNSDirector/PDMR Shareholding
8th Apr 202610:39 amRNSDirector/PDMR Shareholding
30th Mar 202611:01 amRNSNotice of AGM
11th Mar 20261:49 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSFull-year results 2025
11th Feb 20261:27 pmRNSDirector/PDMR Shareholding
13th Jan 20263:43 pmRNSDirector/PDMR Shareholding
11th Dec 20251:29 pmRNSDirector/PDMR Shareholding
11th Nov 20251:40 pmRNSDirector/PDMR Shareholding
31st Oct 20258:00 amRNSTotal Voting Rights
23rd Oct 20259:58 amRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSTrading Update
14th Oct 20257:49 amRNSHolding(s) in Company
13th Oct 20253:56 pmRNSDirector/PDMR Shareholding
3rd Oct 20257:00 amRNSCompletion of Buyback Programme
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 202510:21 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20251:01 pmRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20254:52 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 202512:24 pmRNSDirector/PDMR Shareholding
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.